Predictive Oncology Inc.
POAI
$13.89
-$0.38-2.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.70K | 110.30K | 611.60K | 345.70K | 67.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.70K | 110.30K | 611.60K | 345.70K | 67.30K |
| Cost of Revenue | 18.20K | 45.10K | 290.60K | 196.90K | 13.90K |
| Gross Profit | -15.50K | 65.20K | 321.00K | 148.80K | 53.40K |
| SG&A Expenses | 2.64M | 2.35M | 2.44M | 2.46M | 2.52M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.66M | 2.40M | 2.74M | 2.66M | 2.53M |
| Operating Income | -2.66M | -2.29M | -2.12M | -2.31M | -2.46M |
| Income Before Tax | -1.98M | -2.29M | -2.10M | -2.28M | -2.46M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.98M | -2.29M | -2.10M | -2.28M | -2.46M |
| Earnings from Discontinued Operations | -91.60K | -157.50K | -68.70K | -811.30K | -724.60K |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.07M | -2.44M | -2.17M | -3.09M | -3.18M |
| EBIT | -2.66M | -2.29M | -2.12M | -2.31M | -2.46M |
| EBITDA | -2.63M | -2.25M | -2.08M | -2.27M | -2.43M |
| EPS Basic | -3.41 | -5.12 | -4.87 | -7.26 | -10.23 |
| Normalized Basic EPS | -2.04 | -3.00 | -2.95 | -3.35 | -4.94 |
| EPS Diluted | -3.45 | -5.13 | -4.87 | -7.26 | -10.28 |
| Normalized Diluted EPS | -2.04 | -3.00 | -2.95 | -3.35 | -4.94 |
| Average Basic Shares Outstanding | 607.30K | 476.80K | 445.10K | 426.40K | 311.00K |
| Average Diluted Shares Outstanding | 607.30K | 476.80K | 445.10K | 426.40K | 311.00K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |